The global data monetization solutions for life science companies market size is anticipated to reach USD 956.7 million by 2030, according to a new study by Grand View Research, Inc. The market is projected to grow at a CAGR of 16.5% from 2025 to 2030. The data monetization solutions market for life science companies is rapidly evolving, driven by the increasing recognition of data as a valuable asset and the surge in healthcare digitization. Life science firms embrace data monetization strategies to leverage their vast data repositories effectively. This involves extracting, analyzing, and strategically using data to derive actionable insights, enhance decision-making, and generate additional revenue streams.
Moreover, the emergence of stringent data protection regulations, such as the General Data Protection Regulation (GDPR) in Europe and the California Consumer Privacy Act (CCPA) in the U.S., has significantly increased demands on businesses handling personal data. These regulatory frameworks necessitate robust protection of customer data and empower individuals with greater authority over their data usage. This shift is poised to drive forward more innovative and customer-centric approaches to data monetization in the foreseeable future.
Strategic initiatives by key companies operating in the market enhance their capabilities through acquisitions and the launch of advanced solutions, which can potentially drive market growth for data monetization solutions in the life science sector. For instance, In February 2022, Managed Markets Insight & Technology (MMIT) unveiled Patient Access Analytics. This innovative solution empowers pharmaceutical commercial teams by enabling quick analysis and visualization of various longitudinal, real-world patient datasets. It facilitates immediate access to crucial insights pertaining to access challenges and prescribing trends.
However, this industry transformation is accompanied by challenges such as stringent data privacy regulations, interoperability issues, and the need for advanced analytics capabilities. Overcoming these obstacles while harnessing the potential of data monetization remains pivotal for life science enterprises' sustained growth and competitiveness in today's data-driven landscape.
Request a free sample copy or view report summary: Data Monetization Solutions For Life Science Companies Market Report
The indirect data monetization segment dominated the data monetization solutions for life science companies industry with a revenue share of 63.8% in 2024
The cloud segment dominated the market in 2024 and is anticipated to register the fastest growth with a CAGR of 17.6% over the forecast period
In terms of region, North America has dominated the market in 2024 with the largest revenue share of 40.5%, owing to its well-established and technologically advanced healthcare ecosystem. The region has mature markets, a strong regulatory framework, and a culture of early technology adoption
Grand View Research, Inc. has segmented the global data monetization solutions for life science companies market report based on type, mode of deployment, facility size, and region:
Data Monetization Solutions For Life Science Companies Type Outlook (Revenue, USD Million, 2018 - 2030)
Direct Data Monetization
Software
Services
Indirect Data Monetization
Software
Services
Data Monetization Solutions For Life Science Companies Mode of Deployment Outlook (Revenue, USD Million, 2018 - 2030)
On-Premises
Cloud
Data Monetization Solutions For Life Science Companies Facility Size Outlook (Revenue, USD Million, 2018 - 2030)
Small & Medium Facilities
Large Facilities
Data Monetization Solutions For Life Science Companies Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
Spain
Italy
France
Denmark
Norway
Sweden
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Argentina
MEA
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players of Data Monetization Solutions For Life Science Companies Market
Oracle
Microsoft
Salesforce, Inc.
SAP
SAS Institute Inc.
Accenture
Infosys Limited
Cisco Systems, Inc.
Siemens
Particle Health, Inc.
Snowflake Inc.
"The quality of research they have done for us has been excellent..."